BARX2 and neoplasm: The expression of Human BarH-like homeobox 2 (Barx2), a tumor suppressor linked to the Wnt/β-catenin signaling pathway, was relatively lower in tumor samples than in adjacent samples in NSCLC patients, and low Barx2 expression is associated with poor prognosis.